• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心房颤动在慢性完全闭塞患者中的患病率及影响:来自全国住院患者样本的见解

The Prevalence and Impact of Atrial Fibrillation on Patients with Chronic Total Occlusions: Insights from the National Inpatient Sample.

作者信息

Will Maximilian, Schwarz Konstantin, Holroyd Eric, Borovac Josip A, Qureshi Adnan I, Lip Gregory Y H, Mascherbauer Julia, Leibundgut Gregor, Weiss Thomas W, Kwok Chun Shing

机构信息

Karl Landsteiner University of Health Sciences, Dr. Karl-Dorrek-Straße 30, 3500 Krems, Austria.

Division of Internal Medicine 3, University Hospital St. Pölten, Dunant-Platz 1, 3100 St. Pölten, Austria.

出版信息

J Cardiovasc Dev Dis. 2025 Mar 14;12(3):100. doi: 10.3390/jcdd12030100.

DOI:10.3390/jcdd12030100
PMID:40137098
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11943249/
Abstract

The impact of atrial fibrillation (AF) on patients with chronic total occlusions (CTOs) at the national level remains unclear. In this study, we conducted a retrospective analysis of data from the National Inpatient Sample to assess the characteristics and in-hospital outcomes of patients with CTO based on the presence or absence of AF. Multiple logistic and linear regressions examined factors associated with AF and evaluated its impact on length of stay (LoS), cost, and mortality. The analysis included 480,180 patients diagnosed with CTO, with AF present in 28.0% of cases. Patients with CTOs and AF were older (median age 73 vs. 66 years, < 0.001) and exhibited lower female representation (25.0% vs. 27.9%, < 0.001). Factors most strongly associated with AF included previous heart failure (OR 1.98, 95% CI 1.92-2.05, < 0.001), liver disease (OR 1.37, 95% CI 1.27-1.48, < 0.001), and obesity (OR 1.25, 95% CI 1.20-1.30, < 0.001). AF correlated with increased in-hospital mortality (OR 1.29, 95% CI 1.18-1.40, < 0.001), ischemic stroke (OR 1.27, 95% CI 1.13-1.42, < 0.001), and major bleeding (OR 1.38, 95% CI 1.30-1.46). Moreover, AF was associated with a longer LoS (coef 1.58, 95% CI 1.50 to 1.67, < 0.001) and higher in-hospital costs (coef 6.22, 95% CI 5.81 to 6.63, < 0.001). Patients with CTOs and AF were older and had more underlying health problems compared to patients without AF. The patients with AF have worse outcomes in terms of mortality, ischemic stroke, major bleeding, length of stay, and costs.

摘要

在国家层面,心房颤动(AF)对慢性完全闭塞(CTO)患者的影响仍不明确。在本研究中,我们对国家住院患者样本数据进行了回顾性分析,以评估基于有无AF的CTO患者的特征和住院结局。多元逻辑回归和线性回归分析了与AF相关的因素,并评估了其对住院时间(LoS)、费用和死亡率的影响。该分析纳入了480,180例被诊断为CTO的患者,其中28.0%的病例存在AF。患有CTO且伴有AF的患者年龄更大(中位年龄73岁对66岁,<0.001),女性比例更低(25.0%对27.9%,<0.001)。与AF关联最密切的因素包括既往心力衰竭(OR 1.98,95%CI 1.92 - 2.05,<0.001)、肝病(OR 1.37,95%CI 1.27 - 1.48,<0.001)和肥胖(OR 1.25,95%CI 1.20 - 1.30,<0.001)。AF与住院死亡率增加(OR 1.29,95%CI 1.18 - 1.40,<0.001)、缺血性卒中(OR 1.27,95%CI 1.13 - 1.42,<0.001)及大出血(OR 1.38,95%CI 1.30 - 1.46)相关。此外,AF与更长的住院时间(系数1.58,95%CI 1.50至1.67,<0.001)和更高的住院费用(系数6.22,95%CI 5.81至6.63,<0.001)相关。与无AF的患者相比,患有CTO且伴有AF的患者年龄更大,潜在健康问题更多。伴有AF的患者在死亡率、缺血性卒中、大出血、住院时间和费用方面结局更差。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6172/11943249/22cfb12ebe37/jcdd-12-00100-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6172/11943249/abdfc52ba3ec/jcdd-12-00100-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6172/11943249/22cfb12ebe37/jcdd-12-00100-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6172/11943249/abdfc52ba3ec/jcdd-12-00100-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6172/11943249/22cfb12ebe37/jcdd-12-00100-g002.jpg

相似文献

1
The Prevalence and Impact of Atrial Fibrillation on Patients with Chronic Total Occlusions: Insights from the National Inpatient Sample.心房颤动在慢性完全闭塞患者中的患病率及影响:来自全国住院患者样本的见解
J Cardiovasc Dev Dis. 2025 Mar 14;12(3):100. doi: 10.3390/jcdd12030100.
2
Impact of atrial fibrillation on in-hospital outcomes among hospitalizations for cardiac surgery: an analysis of the National Inpatient Sample.心房颤动对心脏手术住院患者院内结局的影响:国家住院患者样本分析。
J Investig Med. 2022 Apr;70(4):899-906. doi: 10.1136/jim-2021-001864. Epub 2022 Jan 5.
3
Atrial fibrillation and short-term outcomes after cancer-related ischemic stroke.癌症相关性缺血性卒中后的心房颤动及短期预后
Eur Stroke J. 2025 Mar;10(1):108-115. doi: 10.1177/23969873241263402. Epub 2024 Jun 25.
4
Reflux esophagitis is associated with higher risks of acute stroke and transient ischemic attacks in patients hospitalized with atrial fibrillation: A nationwide inpatient sample analysis.反流性食管炎与住院心房颤动患者急性卒中及短暂性脑缺血发作风险增加相关:全国住院患者样本分析。
Medicine (Baltimore). 2021 Jun 25;100(25):e26502. doi: 10.1097/MD.0000000000026502.
5
Outcomes of oesophageal variceal bleeding among patients with atrial fibrillation: a propensity-matched analysis of a nationwide inpatient sample.心房颤动患者食管静脉曲张出血的结局:一项基于全国住院患者样本的倾向评分匹配分析
Arch Med Sci Atheroscler Dis. 2020 Sep 14;5:e255-e262. doi: 10.5114/amsad.2020.98949. eCollection 2020.
6
Burden of Atrial Fibrillation-Associated Ischemic Stroke in the United States.美国心房颤动相关性缺血性卒中的负担。
JACC Clin Electrophysiol. 2018 May;4(5):618-625. doi: 10.1016/j.jacep.2018.02.021. Epub 2018 May 2.
7
Trends, Associations, and Impact of Atrial Fibrillation in Patients With Light-chain Cardiac Amyloidosis.轻链型心脏淀粉样变患者心房颤动的趋势、关联和影响。
Crit Pathw Cardiol. 2021 Sep 1;20(3):168-172. doi: 10.1097/HPC.0000000000000257.
8
Prevalence and outcomes of atrial fibrillation in patients hospitalized with COVID-19.COVID-19 住院患者心房颤动的患病率和结局。
Curr Med Res Opin. 2024 Sep;40(9):1477-1481. doi: 10.1080/03007995.2024.2378179. Epub 2024 Jul 26.
9
Atrial fibrillation after cardiac surgery: a major morbid event?心脏手术后的心房颤动:一种主要的不良事件?
Ann Surg. 1997 Oct;226(4):501-11; discussion 511-3. doi: 10.1097/00000658-199710000-00011.
10
Association of advanced age with procedural complications and in-hospital outcomes from left atrial appendage occlusion device implantation in patients with atrial fibrillation: insights from the National Inpatient Sample of 36,065 procedures.高龄与房颤患者左心耳封堵装置植入术的手术并发症和住院结局相关:来自 36065 例患者的全国住院患者样本的分析。
J Interv Card Electrophysiol. 2022 Oct;65(1):219-226. doi: 10.1007/s10840-022-01266-1. Epub 2022 Jun 22.

本文引用的文献

1
Atrial fibrillation and chronic total occlusion percutaneous coronary intervention outcomes: insights from the Progress-CTO registry.心房颤动与慢性完全闭塞经皮冠状动脉介入治疗结局:来自 Progress-CTO 注册研究的观察。
J Invasive Cardiol. 2023 Aug;35(8). doi: 10.25270/jic/23.00114.
2
Effect of Oral Anticoagulants in Atrial Fibrillation Patients with Polypharmacy: A Meta-analysis.口服抗凝剂对合并多种药物治疗的心房颤动患者的影响:一项荟萃分析。
Thromb Haemost. 2025 Feb;125(2):166-177. doi: 10.1055/s-0043-1770724. Epub 2023 Jul 3.
3
The Impact of Polypharmacy on the Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation.
华法林与非维生素 K 拮抗剂口服抗凝剂在房颤患者中的有效性和安全性。
Thromb Haemost. 2024 Feb;124(2):135-148. doi: 10.1055/s-0043-1769735. Epub 2023 Jun 27.
4
Mobile Health-Technology-Integrated Care for Atrial Fibrillation: A Win Ratio Analysis from the mAFA-II Randomized Clinical Trial.移动医疗技术整合房颤治疗:mAFA-II 随机临床试验的赢率分析。
Thromb Haemost. 2023 Nov;123(11):1042-1048. doi: 10.1055/s-0043-1769612. Epub 2023 May 29.
5
The relationship between atrial fibrillation and coronary artery disease: Understanding common denominators.心房颤动与冠状动脉疾病的关系:了解共同的基础。
Trends Cardiovasc Med. 2024 Feb;34(2):91-98. doi: 10.1016/j.tcm.2022.09.006. Epub 2022 Sep 29.
6
Clinical Complexity Domains, Anticoagulation, and Outcomes in Patients with Atrial Fibrillation: A Report from the GLORIA-AF Registry Phase II and III.心房颤动患者的临床复杂性领域、抗凝治疗与结局:GLORIA-AF 注册研究 II 期和 III 期报告。
Thromb Haemost. 2022 Dec;122(12):2030-2041. doi: 10.1055/s-0042-1756355. Epub 2022 Aug 29.
7
Radial access for chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry.经桡动脉入路慢性完全闭塞病变经皮冠状动脉介入治疗:来自 PROGRESS-CTO 注册研究的见解。
Catheter Cardiovasc Interv. 2022 Nov;100(5):730-736. doi: 10.1002/ccd.30347. Epub 2022 Jul 23.
8
Assessment and Mitigation of Bleeding Risk in Atrial Fibrillation and Venous Thromboembolism: Executive Summary of a European and Asia-Pacific Expert Consensus Paper.房颤和静脉血栓栓塞症出血风险评估与管理:欧洲和亚太专家共识文件的执行摘要。
Thromb Haemost. 2022 Oct;122(10):1625-1652. doi: 10.1055/s-0042-1750385. Epub 2022 Jul 6.
9
2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive Summary.2021 年亚太心律学会心房颤动卒中预防聚焦更新共识指南:执行摘要。
Thromb Haemost. 2022 Jan;122(1):20-47. doi: 10.1055/s-0041-1739411. Epub 2021 Nov 13.
10
Adherence to the 'Atrial Fibrillation Better Care' Pathway in Patients with Atrial Fibrillation: Impact on Clinical Outcomes-A Systematic Review and Meta-Analysis of 285,000 Patients.房颤患者遵循“房颤优化管理路径”:对 28.5 万名患者临床结局的影响——系统评价和荟萃分析。
Thromb Haemost. 2022 Mar;122(3):406-414. doi: 10.1055/a-1515-9630. Epub 2021 Jun 21.